GLP-1 and its derived peptides mediate pain relief through direct TRPV1 inhibition without affecting thermoregulation

참고문헌 (65)

1. Meleger, A. L., "Nutrition and eating behavior in patients with chronic pain receiving long-term opioid therapy", PM R, 6, pp.7~12 (2014)
2. Amy Janke, E., ""The more pain I have, the more I want to eat" : obesity in the context of chronic pain", Obesity, 20, pp.2027~2034 (2012)
3. Foo, H., "Sensory suppression during feeding", Proc. Natl Acad. Sci. USA, 102, pp.16865~16869 (2005)
4. Casey, K. L., "Nocifensive responses to cutaneous thermal stimuli in the cat : stimulus-response profiles, latencies, and afferent activity", J. Neurophysiol, 50, pp.1497~1515 (1983)
5. Wylie, L. M., "Feeding-induced tonic pain suppression in the chicken : reversal by naloxone", Physiol. Behav, 64, pp.27~30 (1998)
6. Foo, H., "Eating is a protected behavior even in the face of persistent pain in male rats", Physiol. Behav, 97, pp.426~429 (2009)
7. Foo, H., "Analgesia accompanying food consumption requires inges tion of hedonic foods", J. Neurosci, 29, pp.13053~13062 (2009)
8. Ossipov, M. H., "Central modulation of pain", J. Clin. Invest, 120, pp.3779~3787 (2010)
9. Fehmann, H. C., "Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide", Endocr. Rev, 16, pp.390~410 (1995)
10. Lim, G. E., "Glucagon-like peptide 1 secretion by the L-cell—the view from within", Diabetes, 55, pp.S70~S77 (2006)
11. Underwood, C. R., "Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor", J. Biol. Chem, 285, pp.723~730 (2010)
12. Brown, E., "Newer GLP-1 receptor agonists and obesity-diabetes", Peptides, 100, pp.61~67 (2018)
13. Gong, N., "Activation of spinal glucagon-like peptide-1 receptors specifically suppresses pain hypersensitivity", J. Neurosci, 34, pp.5322~5334 (2014)
14. Jia, Y., "Peptidic exenatide and herbal catalpol mediate neuroprotection via the hippocampal GLP-1 receptor", beta endorphin pathway, 2015, pp.102, 276~285
15. Ma, L., "Spinal microglial beta-endorphin signaling mediates IL-10 and exenatide-induced inhibition of synaptic plasticity in neuropathic pain", CNS Neurosci. Ther, 27, pp.1157~1172 (2021)
16. Rebosio, C., "Presynaptic GLP-1receptors enhance the depolarization-evoked release of glutamate and GABA in the mouse cortex and hippocampus", Biofactors, 44, pp.148~157 (2018)
17. Wu, H. Y., "p38beta Mitogen-activated protein kinase signaling mediates exenatide-stimulated microglial beta-endorphin expression", Mol. Pharm, 91, pp.451~463 (2017)
18. Wu, H. Y., "Autocrine interleukin-10 mediates glucagon-like peptide-1 receptor-induced spinal microglial beta-endorphin expression", J. Neurosci, 37, pp.11701~11714 (2017)
19. Caterina, M. J., "Impaired nociception and pain sensation in mice lacking the capsaicin receptor", Science, 288, pp.306~313 (2000)
20. Koivisto, A. P., "Advances in TRP channel drug discovery: from target validation to clinical studies", Nat. Rev. Drug Discov, 21, pp.41~59 (2022)
21. Fukuoka, T., "VR1, but not P2X(3), increases in the spared L4 DRG in rats with L5 spinal nerve ligation", Pain, 99, pp.111~120 (2002)
22. Kanai, Y., "Involvement of an increased spinal TRPV1 sensitization through its up-regulation in mechanical allodynia of CCI rats", Neuropharmacology, 49, pp.977~984 (2005)
23. Yamamoto, W., "Characterization of primary sensory neurons mediating static and dynamic allodynia in rat chronic constriction injury model", J. Pharm. Pharm, 60, pp.717~722 (2008)
24. Gavva, N. R., "The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation", J. Neurosci, 27, pp.3366~3374 (2007)
25. Steiner, A. A., "Nonthermal activation of transient receptor potential vanilloid 1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors", J. Neurosci, 27, pp.7459~7468 (2007)
26. Swanson, D. M., "Identification and biological evaluation of 4-(3-tri f luoromethylpyridin-2-yl)piperazine-1-carboxylic acid(5-trifluoromethylpyridin-2yl)amide, a high affinity TRPV1(VR1)vanilloid receptor antagonist", J. Med. Chem, 48, pp.1857~1872 (2005)
27. Gavva, N. R., "Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans", Pain, 136, pp.202~210 (2008)
28. Manitpisitkul, P., "TRPV1 antagonist JNJ-39439335(mavatrep)demonstrates proof of pharmacology in healthy men : a first-in-human, double-blind, placebo controlled, randomized, sequential group study", Pain. Rep, 1, pp.e576~ (2016)
29. Othman, A. A., "Effects of the TRPV1 antagonist ABT-102 on body temperature in healthy volunteers: pharmacokinetic", pharma codynamic analysis of three phase 1 trials, 2013, pp.75, 1029~1040
30. Round, P., "An investigation of the safety and phar macokinetics of the novel TRPV1 antagonist XEN-D0501 in healthy subjects", Br. J. Clin. Pharm, 72, pp.921~931 (2011)
31. Rowbotham, M. C., "Oral and cutaneous thermosensory profile of selective TRPV1 inhibition by ABT-102 in a randomized healthy volunteer trial", Pain, 152, pp.1192~1200 (2011)
32. Garami, A., "TRPV1 antagonists that cause hypothermia, instead of hyper thermia, in rodents : compounds’ pharmacological profiles, in vivo targets, ther moeffectors recruited and implications for drug development", Acta Physiol, 223, pp.e13038~ (2018)
33. Lehto, S. G., "Antihyperalgesic effects of(R, E)-N-(2-hydroxy-2, 3-dihydro-1H inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide(AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats", J. Pharm. Exp. Ther, 326, pp.218~229 (2008)
34. Mills, C., "Effects of the transient receptor potential vanilloid 1 antagonist A-425619 on body temperature and thermoregulation in the rat", Neuroscience, 156, pp.165~174 (2008)
35. Garami, A., "Contributions of different modes of TRPV1 activation to TRPV1antagonist-induced hyperthermia", J. Neurosci, 30, pp.1435~1440 (2010)
36. Rahman, M. M., "Diosgenin exerts analgesic effects by antagonizing the selective inhibition of transient receptor potential vanilloid 1in a mouse model of neuropathic pain", Int. J. Mol. Sci, 23, pp.15854~ (2022)
37. Holst, J. J., "Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans", Am. J. Physiol. Endocrinol. Metab, 287, pp.E199~E206 (2004)
38. Schirra, J., "Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(736)amide in humans", J. Clin. Invest, 101, pp.1421~1430 (1998)
39. Deacon, C. F., "Therapeutic strategies based on glucagon-like peptide 1", Diabetes, 53, pp.2181~2189 (2004)
40. Valenzano, K. J., "N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetra hydropyrazine-1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. in vitro characterization and pharmacokinetic properties", J. Pharm. Exp. Ther, 306, pp.377~386 (2003)
41. Gavva, N. R., "Repeated administration of vanilloid receptor TRPV1 antago nists attenuates hyperthermia elicited by TRPV1 blockade", J. Pharm. Exp. Ther, 323, pp.128~137 (2007)
42. Garami, A., "Hyperthermia induced by transient receptor potential vanilloid-1(TRPV1)antagonists in human clinical trials : insights from mathematical modeling and meta-analysis", Pharm. Ther, 208, pp.107474~ (2020)
43. Luo, H., "Change of vanilloid receptor 1 expression in dorsal root ganglion and spinal dorsal horn during inflammatory nociception induced by complete Freund’s adjuvant in rats", Neuroreport, 15, pp.655~658 (2004)
44. Vilceanu, D., "Spinal nerve ligation in mouse upregulates TRPV1 heat function in injured IB4-positive nociceptors", J. Pain, 11, pp.588~599 (2010)
45. Gavva, N. R., "Proton activation does not alter antagonist interaction with the capsaicin-binding pocket of TRPV1", Mol. Pharm, 68, pp.1524~1533 (2005)
46. Sedman, T., "Tolerance develops toward GLP-1 receptor agonists’ glucose-lowering effect in mice", Eur. J. Pharm, 885, pp.173443~ (2020)
47. Yamamoto, R. T., "Antinociceptive actions of peripheral glucose administration", Pharm. Biochem. Behav, 117, pp.34~39 (2014)
48. Davis, J. B., "Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia", Nature, 405, pp.183~187 (2000)
49. Mercadante, S., "Opioid-induced tolerance and hyper algesia", CNS Drugs, 33, pp.943~955 (2019)
50. Wang, Z., "Anti-PD-1 treatment impairs opioid antinociception in rodents and nonhuman primates", Sci. Transl. Med, 12, pp.eaaw6471~ (2020)
51. Szallasi, A., "The vanilloid receptor TRPV1 : 10years from channel cloning to antagonist proof-of-concept", Nat. Rev. Drug Discov, 6, pp.357~372 (2007)
52. Fujita, S., "Exenatide facilitates recovery from oxaliplatin-induced peripheral neuropathy in rats", PLoS ONE, 10, pp.e0141921~ (2015)
53. Himeno, T., "Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice", Diabetes, 60, pp.2397~2406 (2011)
54. Kan, M., "Glucagon-like peptide 1, insulin, sensory neurons, and diabetic neuropathy", J. Neuropathol. Exp. Neurol, 71, pp.494~510 (2012)
55. Liu, W. J., "Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats", Br. J. Pharm, 164, pp.1410~1420 (2011)
56. Ji, R. R., "p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia", Neuron, 36, pp.57~68 (2002)
57. Yu, L., "The role of TRPV1 in different subtypes of dorsal root ganglion neurons in rat chronic inflammatory nociception induced by complete Freund’s adjuvant", Mol. Pain, 4, pp.61~ (2008)
58. Yang, F., "Understand spiciness : mechanism of TRPV1 channel acti vation by capsaicin", Protein Cell, 8, pp.169~177 (2017)
59. Carlton, S. M., "Peripheral capsaicin receptors increase in the inflamed rat hindpaw : a possible mechanism for peripheral sensitization", Neu rosci. Lett, 310, pp.53~56 (2001)
60. Jing, F., "GLP-1R agonist liraglutide attenuates pain hypersensi tivity by stimulating IL-10 release in a nitroglycerin-induced chronic migraine mouse model", Neurosci. Lett, 812, pp.137397~ (2023)
61. Krajnc, N., "Treatment with GLP-1 receptor agonists is associated with sig nificant weight loss and favorable headache outcomes in idiopathic intracranial hypertension", J. Headache Pain, 24, pp.89~ (2023)
62. Mayer, F., "Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide stimulate release of substance P from TRPV1-and TRPA1-expressing sensory nerves", Am. J. Physiol. Gastrointest. Liver Physiol, 319, pp.G23~G35 (2020)
63. Mayendraraj, A., "GLP-1 and GIP receptor signaling in beta cells—a review of receptor interactions and co-stimulation", Peptides, 151, pp.170749~ (2022)
64. Jumper, J., "Highly accurate protein structure prediction with AlphaFold", Nature, 596, pp.583~589 (2021)
65. Zhang, K., "Structural snapshots of TRPV1 reveal mechanism of polymodal functionality", Cell, 184, pp.5138~5150 (2021)

관련 논문AI추천